胰岛素抵抗稳态模型评估指数与2型糖尿病 合并抑郁症的相关性研究
Study on the Correlation between the Homeostatic Model Assessment Index of Insulin Resistance and Type 2 Diabetes Mellitus Complicated with Depression
DOI: 10.12677/acm.2026.162663, PDF,    科研立项经费支持
作者: 王轶坤, 钟 兴*:安徽医科大学第二附属医院内分泌科,安徽 合肥
关键词: 2型糖尿病抑郁症胰岛素抵抗Type 2 Diabetes Mellitus Depression Insulin Resistance
摘要: 目的:探讨胰岛素抵抗稳态模型评估指数与2型糖尿病合并抑郁症的相关性。方法:纳入2024年5月1日至2025年4月30日期间,于安徽医科大学第二附属医院内分泌科门诊及病房接受随访的2型糖尿病(T2DM)患者。收集人口学、临床、实验室资料,根据患者PHQ-9的评分将研究对象分为抑郁组与非抑郁组,比较两组患者临床特征。采用多因素logistic回归模型分析胰岛素抵抗指数与T2DM抑郁症的关系,构建包含常规危险因素的完全调整模型;同时在年龄、性别、病程、BMI等亚组中进行分层分析,利用限制性立方样条模型(RCS)曲线评估HOMA2IR (胰岛素抵抗指数)与抑郁的非线性关系,受试者工作特征(ROC)曲线分析HOMA-IR对T2DM抑郁症患者的预测价值。结果:本研究共纳入465例T2DM患者,年龄(55.24 ± 13.23)岁,其中男性292例(62.8%)。抑郁组218例(46.9%),非抑郁组247例(53.1%)。抑郁组HOMA2IR水平高于非抑郁组[1.92 (1.51, 2.49)比1.80 (1.29, 2.11), p < 0.001]。HOMA2IR升高(OR = 1.75, 95% CI: 1.32~2.32)是T2DM抑郁症的危险因素。按四分位分组后,最高四分位组抑郁评分为最低四分位组的2.66倍(OR = 2.66, 95% CI: 1.57~4.51)。将HOMA2IR纳入完全调整模型后,HOMA2IR与T2DM抑郁的关系进一步增强(OR = 1.87, 95% CI: 1.39~2.53, p < 0.001)。亚组分析显示,HOMA2IR在年龄 < 60岁(p < 0.01)、高血压患者(p < 0.01)中的预测价值更为显著。ROC曲线分析显示,HOMA-IR对T2DM抑郁症有预测价值,最佳临界值为2.465。结论:HOMA2IR是T2DM患者发生抑郁的独立危险因素,并且具有预测价值。即当HOMA2IR达到2.465时,需警惕患者糖尿病合并抑郁症。
Abstract: Objective: To explore the correlation between the homeostasis model assessment index of insulin resistance and diabetic depression. Methods: A prospective study was conducted on patients with type 2 diabetes who were followed up at the outpatient clinic and inpatient wards of the Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, from May 1, 2024, to April 30, 2025. Demographic, clinical, and laboratory data were collected. The subjects were divided into a depression group and a non-depression group based on their PHQ-9 scores. The clinical characteristics of the two groups were compared. A multivariate logistic regression model was used to analyze the relationship between the insulin resistance index and diabetic depression, and a fully adjusted model including conventional risk factors was constructed. Meanwhile, stratified analyses were performed in subgroups such as age, gender, disease duration, and BMI. Restricted cubic spline (RCS) curves were used to evaluate the non-linear relationship between HOMA2IR (insulin resistance index) and depression, and receiver operating characteristic (ROC) curves were used to analyze the predictive value of HOMA-IR for patients with type 2 diabetic depression. Results: A total of 465 patients with type 2 diabetes were included in this study, with an age of (55.24 ± 13.23) years, including 292 males (62.8%). There were 218 cases in the depression group (46.9%) and 247 cases in the non-depression group (53.1%). The level of HOMA2IR in the depression group was higher than that in the non-depression group [1.92 (1.51, 2.49) vs. 1.80 (1.29, 2.11), p < 0.001]. An increase in HOMA2IR (OR = 1.75, 95% CI: 1.32~2.32) was a risk factor for diabetic depression. After grouping by quartiles, the depression score in the highest quartile group was 2.66 times that of the lowest quartile group (OR = 2.66, 95% CI: 1.57~4.51). After including HOMA2IR in the fully adjusted model, the relationship between HOMA2IR and diabetic depression was further strengthened (OR = 1.87, 95% CI: 1.39~2.53, p < 0.001). Subgroup analysis showed that the predictive value of HOMA2IR was more significant in patients aged < 60 years (p < 0.01) and those with hypertension (p < 0.01). ROC curve analysis showed that HOMA-IR had predictive value for diabetic depression, with the optimal cut-off value being 2.465. Conclusion: HOMA2IR is an independent risk factor for depression in patients with T2DM, and HOMA2IR has predictive value for diabetic depression. That is, when HOMA2IR reaches 2.465, vigilance should be paid to patients with diabetes complicated by depression.
文章引用:王轶坤, 钟兴. 胰岛素抵抗稳态模型评估指数与2型糖尿病 合并抑郁症的相关性研究[J]. 临床医学进展, 2026, 16(2): 2554-2567. https://doi.org/10.12677/acm.2026.162663

参考文献

[1] Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. [Google Scholar] [CrossRef] [PubMed]
[2] Pomytkin, I. and Pinelis, V. (2021) Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions. Life, 11, Article 262. [Google Scholar] [CrossRef] [PubMed]
[3] Fernandes, B.S., Salagre, E., Enduru, N., Grande, I., Vieta, E. and Zhao, Z. (2022) Insulin Resistance in Depression: A Large Meta-Analysis of Metabolic Parameters and Variation. Neuroscience & Biobehavioral Reviews, 139, Article ID: 104758. [Google Scholar] [CrossRef] [PubMed]
[4] Matlock, K.A., Albright‐Pierce, M.R., Bermúdez‐Millán, A., Pérez‐Escamilla, R., Segura‐Pérez, S. and Wagner, J. (2024) Urban Environmental Threat Moderates the Relationship between Depression and Insulin Resistance among Latinxs with Type 2 Diabetes. Stress and Health, 40, e3504. [Google Scholar] [CrossRef] [PubMed]
[5] Gruber, J., Hanssen, R., Qubad, M., Bouzouina, A., Schack, V., Sochor, H., et al. (2023) Impact of Insulin and Insulin Resistance on Brain Dopamine Signalling and Reward Processing—An Underexplored Mechanism in the Pathophysiology of Depression? Neuroscience & Biobehavioral Reviews, 149, Article ID: 105179. [Google Scholar] [CrossRef] [PubMed]
[6] Lann, D. and LeRoith, D. (2007) Insulin Resistance as the Underlying Cause for the Metabolic Syndrome. Medical Clinics of North America, 91, 1063-1077. [Google Scholar] [CrossRef] [PubMed]
[7] Yu, C., Liu, L., Lu, Z., Chen, M., Yang, N., Li, Z., et al. (2026) A New Approach for Treating AD: Guifu Dihuang Pills Improves Brain Insulin Resistance by Promoting NrCAM to Activate the EGFR/PI3K/Akt Signaling Pathway. Journal of Ethnopharmacology, 356, Article ID: 120642. [Google Scholar] [CrossRef
[8] Yao, J., Zhu, C., Sun, Y., Huang, Y., Li, Q., Liao, H., et al. (2025) Insulin Resistance: The Role in Comorbid Type 2 Diabetes Mellitus and Depression. Neuroscience & Biobehavioral Reviews, 175, Article ID: 106218. [Google Scholar] [CrossRef] [PubMed]
[9] Alberti, K.G.M.M. and Zimmet, P.Z. (1998) Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabetic Medicine, 15, 539-553. [Google Scholar] [CrossRef] [PubMed]
[10] 杨坤, 胡义秋, 崔景秋, 等. 糖尿病抑郁综合征的研究进展[J]. 国际精神病学杂志, 2015, 42(1): 90-94.
[11] Renn, B.N., Feliciano, L. and Segal, D.L. (2011) The Bidirectional Relationship of Depression and Diabetes: A Systematic Review. Clinical Psychology Review, 31, 1239-1246. [Google Scholar] [CrossRef] [PubMed]
[12] Bot, M., Pouwer, F., Zuidersma, M., van Melle, J.P. and de Jonge, P. (2012) Association of Coexisting Diabetes and Depression with Mortality after Myocardial Infarction. Diabetes Care, 35, 503-509. [Google Scholar] [CrossRef] [PubMed]
[13] Eaton, W.W., Armenian, H., Gallo, J., Pratt, L. and Ford, D.E. (1996) Depression and Risk for Onset of Type II Diabetes: A Prospective Population-Based Study. Diabetes Care, 19, 1097-1102. [Google Scholar] [CrossRef] [PubMed]
[14] Simon, G.E., Von Korff, M., Saunders, K., Miglioretti, D.L., Crane, P.K., van Belle, G., et al. (2006) Association between Obesity and Psychiatric Disorders in the US Adult Population. Archives of General Psychiatry, 63, 824-830. [Google Scholar] [CrossRef] [PubMed]
[15] Mezuk, B., Eaton, W.W., Albrecht, S. and Golden, S.H. (2008) Depression and Type 2 Diabetes over the Lifespan. Diabetes Care, 31, 2383-2390. [Google Scholar] [CrossRef] [PubMed]
[16] Rasgon, N.L. and McEwen, B.S. (2016) Insulin Resistance—A Missing Link No More. Molecular Psychiatry, 21, 1648-1652. [Google Scholar] [CrossRef] [PubMed]
[17] Bomfim, T.R., Forny-Germano, L., Sathler, L.B., Brito-Moreira, J., Houzel, J., Decker, H., et al. (2012) An Anti-Diabetes Agent Protects the Mouse Brain from Defective Insulin Signaling Caused by Alzheimer’s Disease-Associated Aβ Oligomers. Journal of Clinical Investigation, 122, 1339-1353. [Google Scholar] [CrossRef] [PubMed]
[18] Talbot, K., Wang, H., Kazi, H., Han, L., Bakshi, K.P., Stucky, A., et al. (2012) Demonstrated Brain Insulin Resistance in Alzheimer’s Disease Patients Is Associated with IGF-1 Resistance, IRS-1 Dysregulation, and Cognitive Decline. Journal of Clinical Investigation, 122, 1316-1338. [Google Scholar] [CrossRef] [PubMed]
[19] Singh, M.K., Leslie, S.M., Packer, M.M., Zaiko, Y.V., Phillips, O.R., Weisman, E.F., et al. (2019) Brain and Behavioral Correlates of Insulin Resistance in Youth with Depression and Obesity. Hormones and Behavior, 108, 73-83. [Google Scholar] [CrossRef] [PubMed]
[20] Prpić-Križevac, I., Canecki-Varžić, S. and Bilić-Ćurčić, I. (2012) Hyperactivity of the Hypothalamic-Pituitary-Adrenal Axis in Patients with Type 2 Diabetes and Relations with Insulin Resistance and Chronic Complications. Wiener klinische Wochenschrift, 124, 403-411. [Google Scholar] [CrossRef] [PubMed]
[21] Nikkheslat, N., Zunszain, P.A., Horowitz, M.A., Barbosa, I.G., Parker, J.A., Myint, A., et al. (2015) Insufficient Glucocorticoid Signaling and Elevated Inflammation in Coronary Heart Disease Patients with Comorbid Depression. Brain, Behavior, and Immunity, 48, 8-18. [Google Scholar] [CrossRef] [PubMed]
[22] Xia, W., Wang, S., Spaeth, A.M., Rao, H., Wang, P., Yang, Y., et al. (2015) Insulin Resistance-Associated Interhemispheric Functional Connectivity Alterations in T2DM: A Resting-State fMRI Study. BioMed Research International, 2015, Article ID: 719076. [Google Scholar] [CrossRef] [PubMed]
[23] Xia, W., Chen, Y., Luo, Y., Zhang, D., Chen, H., Ma, J., et al. (2019) Alterations in Effective Connectivity within the Papez Circuit Are Correlated with Insulin Resistance in T2DM Patients without Mild Cognitive Impairment. Brain Imaging and Behavior, 14, 1238-1246. [Google Scholar] [CrossRef] [PubMed]
[24] Ohara, M., Watanabe, K., Suzuki, T., Sekimizu, K., Motoyama, M., Ishii, K., et al. (2013) Improving in the Fasting, but Not the Postprandial, Glucose Level Is Associated with Reduction of Plasma D-ROMs Level in Patients with Type 2 Diabetes. Journal of Nippon Medical School, 80, 200-210. [Google Scholar] [CrossRef] [PubMed]
[25] Maciejczyk, M., Żebrowska, E., Zalewska, A. and Chabowski, A. (2018) Redox Balance, Antioxidant Defense, and Oxidative Damage in the Hypothalamus and Cerebral Cortex of Rats with High Fat Diet‐induced Insulin Resistance. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 6940515. [Google Scholar] [CrossRef] [PubMed]
[26] De Felice, F.G. and Ferreira, S.T. (2014) Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease. Diabetes, 63, 2262-2272. [Google Scholar] [CrossRef] [PubMed]
[27] Luca, M., Di Mauro, M., Di Mauro, M. and Luca, A. (2019) Gut Microbiota in Alzheimer’s Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 4730539. [Google Scholar] [CrossRef] [PubMed]
[28] Correia, A.S., Cardoso, A. and Vale, N. (2023) Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin, Neurogenesis and Synaptic Plasticity. Antioxidants, 12, Article 470. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, Y., Liang, F., Tian, H., Luo, D., Wang, Y. and Yang, S. (2023) Mechanisms of Gut Microbiota-Immune-Host Interaction on Glucose Regulation in Type 2 Diabetes. Frontiers in Microbiology, 14, Article 1121695. [Google Scholar] [CrossRef] [PubMed]
[30] Slyepchenko, A., Maes, M., Machado-Vieira, R., Anderson, G., Solmi, M., Sanz, Y., et al. (2016) Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links between Depression, Obesity and Type 2 Diabetes. Current Pharmaceutical Design, 22, 6087-6106. [Google Scholar] [CrossRef] [PubMed]
[31] Chaves Filho, A.J.M., Lima, C.N.C., Vasconcelos, S.M.M., de Lucena, D.F., Maes, M. and Macedo, D. (2018) IDO Chronic Immune Activation and Tryptophan Metabolic Pathway: A Potential Pathophysiological Link between Depression and Obesity. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 80, 234-249. [Google Scholar] [CrossRef] [PubMed]
[32] Li, S., Yang, D., Zhou, X., Chen, L., Liu, L., Lin, R., et al. (2023) Neurological and Metabolic Related Pathophysiologies and Treatment of Comorbid Diabetes with Depression. CNS Neuroscience & Therapeutics, 30, e14497. [Google Scholar] [CrossRef] [PubMed]